This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 19Nov 2019

    Thesis defence Francine Voncken: personalize oesophageal cancer treatment

    Patients with locally advanced oesophageal cancer, who are treated with radiotherapy and chemotherapy, are currently receiving more or less uniform treatments. However, there are major differences between patients.

    Read More
  • 04Nov 2019

    Netherlands Cancer Institute uses a 3D MRI video in radiotherapy for the first time in Europe

    The Netherlands Cancer Institute has become the first in Europe to administer radiation therapy to a cancer patient using a 3D MRI video. Doctors and researchers at the Amsterdam comprehensive cancer center have developed software that they can use to make a video of a tumour as it moves - due to the patient's breathing for example.

    Read More
  • 31Oct 2019

    Thesis defense Meta van Lanschot: towards better surveillance methods for high-risk CRC patients

    On 29 October, Meta van Lanschot from the molecular pathology group of Gerrit Meijer at the NKI defende her thesis, entitled 'Early detection of colorectal cancer. Towards better surveillance'. Meta van Lanschot defended her thesis at Utrecht University.

    Read More
  • 24Oct 2019

    DNA map of metastasised cancer provides opportunities for treatment

    Dutch researchers, including three oncologists at the Netherlands Cancer Institute, have been the first to map the landscape of DNA errors in thousands of metastasised tumours. The study was published on Wednesday 23 October in the leading scientific journal Nature. It also gave rise to the DRUP study in 2016, and to the WIDE-study in 2019.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2016 805
Total impact of publications in 2014 3935
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page